Literature DB >> 21130853

Yokukansan, a kampo medicine, protects against glutamate cytotoxicity due to oxidative stress in PC12 cells.

Zenji Kawakami1, Hitomi Kanno, Yasushi Ikarashi, Yoshio Kase.   

Abstract

AIM OF THE STUDY: Yokukansan is a traditional Japanese medicine consisted of seven medicinal herbs and has been used for treatment of neurosis, insomnia, and behavioral and psychological symptoms of dementia in Japan. The aim of the present study is to clarify the active compounds responsible for the protective effect of yokukansan against glutamate-induced cytotoxicity in PC12 cells.
MATERIALS AND METHODS: PC12 cells which is a tool for selective evaluation of test substances against oxidative stress was used in the present study. The cell survival rates or glutathione (GSH) levels were evaluated by a MTT reduction assay or GSH assay based on the GSH reductase enzymatic recycling method, respectively.
RESULTS: Glutamate (1-17.5mM) induced cell death of PC12 cells in a concentration- dependent manner. Yokukansan (125-500μg/ml) inhibited the glutamate-induced PC12 cell death. When the effects of extracts of the seven constituent herbs in yokukansan on the cell death were examined, Uncaria thorn was found to have the highest potency in the protection. To clarify the active compounds in Uncaria thorn, the effects of seven alkaloids (rhynchophylline, isorhynchophylline, corynoxeine, isocorynoxeine, hirsutine, hirsuteine, and geissoschizine methyl ether) on the cell death were further examined. The protective effects were found in hirsutine, hirsuteine, and geissoschizine methyl ether, which also ameliorated the glutamate-induced decrease in GSH levels.
CONCLUSION: These results suggest that yokukansan protects against PC12 cell death induced by glutamate-mediated oxidative stress, i.e., reduction of intracellular GSH level, and the effect may be mainly attributed to a synergistic effect of the hirsutine, hirsuteine, and geissoschizine methyl ether in Uncaria thorn.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21130853     DOI: 10.1016/j.jep.2010.11.063

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  26 in total

1.  Preconditioning with Gua Lou Gui Zhi decoction enhances H2O2-induced Nrf2/HO-1 activation in PC12 cells.

Authors:  Jingjie Mao; Zuanfang Li; Ruhui Lin; Xiaoqin Zhu; Jiumao Lin; Jun Peng; Lidian Chen
Journal:  Exp Ther Med       Date:  2015-07-01       Impact factor: 2.447

2.  Curcumin-Protected PC12 Cells Against Glutamate-Induced Oxidative Toxicity.

Authors:  Chi-Huang Chang; Hua-Xin Chen; George Yü; Chiung-Chi Peng; Robert Y Peng
Journal:  Food Technol Biotechnol       Date:  2014-12       Impact factor: 3.918

3.  Isoliquiritigenin is a novel NMDA receptor antagonist in kampo medicine yokukansan.

Authors:  Zenji Kawakami; Yasushi Ikarashi; Yoshio Kase
Journal:  Cell Mol Neurobiol       Date:  2011-06-21       Impact factor: 5.046

4.  Minocycline reduces oxygen-glucose deprivation-induced PC12 cell cytotoxicity via matrix metalloproteinase-9, integrin β1 and phosphorylated Akt modulation.

Authors:  Xiaohong Chen; Shaoqiong Chen; Ying Jiang; Cansheng Zhu; Aimin Wu; Xiaomeng Ma; Fuhua Peng; Lili Ma; Dongliang Zhu; Qing Wang; Rongbiao Pi
Journal:  Neurol Sci       Date:  2012-12-07       Impact factor: 3.307

5.  Geissoschizine methyl ether protects oxidative stress-mediated cytotoxicity in neurons through the 'Neuronal Warburg Effect'.

Authors:  Jiahong Sun; Xuefang Ren; Wen Qi; Dan Yuan; James W Simpkins
Journal:  J Ethnopharmacol       Date:  2016-04-22       Impact factor: 4.360

6.  An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease.

Authors:  Taku Hatano; Nobutaka Hattori; Tadaaki Kawanabe; Yasuo Terayama; Norihiro Suzuki; Yasuo Iwasaki; Toshiki Fujioka
Journal:  J Neural Transm (Vienna)       Date:  2013-10-30       Impact factor: 3.575

7.  Bioassay-Guided Isolation of Neuroprotective Compounds from Uncaria rhynchophylla against Beta-Amyloid-Induced Neurotoxicity.

Authors:  Yan-Fang Xian; Zhi-Xiu Lin; Qing-Qiu Mao; Zhen Hu; Ming Zhao; Chun-Tao Che; Siu-Po Ip
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-20       Impact factor: 2.629

8.  Yokukansan, a kampo medicine, protects PC12 cells from glutamate-induced death by augmenting gene expression of cystine/glutamate antiporter system Xc-.

Authors:  Hitomi Kanno; Zenji Kawakami; Kazushige Mizoguchi; Yasushi Ikarashi; Yoshio Kase
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

9.  Analgesic Effect of Combined Therapy with the Japanese Herbal Medicine "Yokukansan" and Electroacupuncture in Rats with Acute Inflammatory Pain.

Authors:  Nachi Ebihara; Hideshi Ikemoto; Naoki Adachi; Takayuki Okumo; Taro Kimura; Kanako Yusa; Satoshi Hattori; Atsufumi Manabe; Tadashi Hisamitsu; Masataka Sunagawa
Journal:  Medicines (Basel)       Date:  2021-06-17

Review 10.  Yokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditions.

Authors:  Hideki Okamoto; Masaomi Iyo; Keigo Ueda; Cheolsun Han; Yoshiro Hirasaki; Takao Namiki
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.